Effect of chlorpromazine on rat arterial lipid synthesis, in vitro
The effect of chlorpromazine, a major tranquilizer, on arterial lipid metabolism was studied in vitro in rat aortas incubated with (/sup 14/C)acetate and (/sup 14/C)mevalonate as lipid precursors. Chlorpromazine at a level of 0.25 mM in the incubation medium significantly reduced the incorporation of (/sup 14/C)acetate into free fatty acids (p less than 0.01) and total phospholipids (p less than 0.001) but not triglycerides. Chlorpromazine also altered the pattern of arterial phospholipids synthesized from (/sup 14/C)acetate by significantly increasing the relative proportion of phosphatidylinositol plus phosphatidylserine (p less than 0.02) and reducing the relative proportion of sphingomyelin (p less than 0.001). (/sup 14/C) Acetate incorporation into the combined fractions of steryl esters plus hydrocarbons and sterols plus diglycerides was also significantly reduced (p less than 0.001) by 0.25 mM chlorpromazine. Studies with (/sup 14/C)mevalonate showed that chlorpromazine is also an inhibitor of sterol biosynthesis in arterial tissues as evidenced by 35-40% reductions (p less than 0.05) in the formation of /sup 14/C-labeled squalene and C27 sterols.
- Research Organization:
- Diabetes and Athersclerosis Research, The Upjohn Company, Kalamazoo, MI
- OSTI ID:
- 6253512
- Journal Information:
- Lipids; (United States), Vol. 17:10
- Country of Publication:
- United States
- Language:
- English
Similar Records
Membrane lipid metabolism in germinating castor bean endosperm
Metabolic fate of radiolabeled palmitate in ischemic canine myocardium: implications for positron emission tomography
Related Subjects
CHLORPROMAZINE
BIOLOGICAL EFFECTS
METABOLISM
LIPIDS
BIOSYNTHESIS
AORTA
BIOCHEMICAL REACTION KINETICS
CARBON 14 COMPOUNDS
CARBOXYLIC ACIDS
IN VITRO
ISOTOPE APPLICATIONS
MOLECULAR BIOLOGY
RATS
RESEARCH PROGRAMS
TRACER TECHNIQUES
USA
AMINES
ANIMALS
ARTERIES
AZINES
BLOOD VESSELS
BODY
CARDIOVASCULAR SYSTEM
CENTRAL NERVOUS SYSTEM AGENTS
CENTRAL NERVOUS SYSTEM DEPRESSANTS
DRUGS
HETEROCYCLIC COMPOUNDS
HYPNOTICS AND SEDATIVES
KINETICS
LABELLED COMPOUNDS
MAMMALS
NORTH AMERICA
ORGANIC ACIDS
ORGANIC CHLORINE COMPOUNDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANIC NITROGEN COMPOUNDS
ORGANIC SULFUR COMPOUNDS
ORGANS
PHENOTHIAZINES
PSYCHOTROPIC DRUGS
REACTION KINETICS
RODENTS
SYNTHESIS
TRANQUILIZERS
VERTEBRATES
550501* - Metabolism- Tracer Techniques